Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groups
U Creutzig, M Zimmermann, D Reinhardt, M Rasche… - Cancer, 2016 - Wiley Online Library
BACKGROUND To obtain better insight into the biology of acute myeloid leukemia (AML) in
various age groups, this study focused on the genetic changes occurring during a lifetime …
various age groups, this study focused on the genetic changes occurring during a lifetime …
Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study
JDE De Rooij, R Masetti… - Blood, The Journal …, 2016 - ashpublications.org
Genetic abnormalities and early treatment response are the main prognostic factors in acute
myeloid leukemia (AML). Acute megakaryoblastic leukemia (AMKL) is a rare subtype of …
myeloid leukemia (AML). Acute megakaryoblastic leukemia (AMKL) is a rare subtype of …
[HTML][HTML] Cytogenetic profile in 7209 Indian patients with de novo acute leukemia: a single centre study from India
PSK Amare, H Jain, S Kabre, Y Deshpande… - Journal of Cancer …, 2016 - scirp.org
Background: Cytogenetics is one of the most important diagnostic parameters in the
classification of acute leukemia. Recurrent chromosomal aberrations in acute leukemia have …
classification of acute leukemia. Recurrent chromosomal aberrations in acute leukemia have …
Acute myeloid leukemia in adolescents and young adults treated in pediatric and adult departments in the Nordic countries
L Wennström, PW Edslev… - Pediatric Blood & …, 2016 - Wiley Online Library
Background Studies on adolescents and young adults with acute lymphoblastic leukemia
suggest better results when using pediatric protocols for adult patients, while corresponding …
suggest better results when using pediatric protocols for adult patients, while corresponding …
Predictors of early death and survival among children, adolescents and young adults with acute myeloid leukaemia in California, 1988–2011: a population‐based …
R Abrahão, RH Keogh, DY Lichtensztajn… - British journal of …, 2016 - Wiley Online Library
A better understanding of factors associated with early death and survival among children,
adolescents and young adults with acute myeloid leukaemia (AML) may guide health policy …
adolescents and young adults with acute myeloid leukaemia (AML) may guide health policy …
Clinical characteristics and outcome of childhood de novo acute myeloid leukemia in Saudi Arabia: A multicenter SAPHOS leukemia group study
W Jastaniah, I Al Ghemlas, S Al Daama, W Ballourah… - Leukemia research, 2016 - Elsevier
Geographic variation and ethnicity have been implicated to influence the outcome of
pediatric acute myeloid leukemia (AML). Furthermore, survival outcomes from developing …
pediatric acute myeloid leukemia (AML). Furthermore, survival outcomes from developing …
Trisomy 8 in pediatric acute myeloid leukemia: A NOPHO‐AML study
ACL Laursen, JD Sandahl, E Kjeldsen… - Genes …, 2016 - Wiley Online Library
Trisomy 8 (+ 8) is a common cytogenetic aberration in acute myeloid leukemia (AML);
however, the impact of+ 8 in pediatric AML is largely unknown. We retrospectively …
however, the impact of+ 8 in pediatric AML is largely unknown. We retrospectively …
The prognostic significance of trisomy 4 in acute myeloid leukaemia is dependent on age and additional abnormalities
1 Vachon CM, Kyle RA, Therneau TM, Foreman BJ, Larson DR, Colby CL et al. Increased
risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or …
risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or …
Hibridación in situ fluorescente: herramienta en el diagnóstico de las hemopatías malignas
K Lavaut Sánchez, N Hernández Aguilar… - Revista Cubana de …, 2016 - scielo.sld.cu
Introducción: las neoplasias hematológicas tienen origen clonal y se caracterizan por
presentar gran heterogeneidad genética. El desarrollo de la citogenética molecular a través …
presentar gran heterogeneidad genética. El desarrollo de la citogenética molecular a través …
[HTML][HTML] Correlation of NPM1 type A mutation burden with clinical status and outcomes in acute myeloid leukemia patients with mutated NPM1 type A
SY Jo, SH Park, IS Kim, J Yi, HH Kim… - Annals of laboratory …, 2016 - ncbi.nlm.nih.gov
Background Nucleophosmin gene (NPM1) mutation may be a good molecular marker for
assessing the clinical status and predicting the outcomes in AML patients. We evaluated the …
assessing the clinical status and predicting the outcomes in AML patients. We evaluated the …